While MBX Biosciences Inc has overperformed by 3.91%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MBX rose by 48.62%, with highs and lows ranging from $26.65 to $4.81, whereas the simple moving average jumped by 115.48% in the last 200 days.
On November 04, 2025, TD Cowen started tracking MBX Biosciences Inc (NASDAQ: MBX) recommending Buy. A report published by Truist on October 15, 2025, Initiated its previous ‘Buy’ rating for MBX. Jefferies also rated MBX shares as ‘Buy’, setting a target price of $36 on the company’s shares in an initiating report dated August 15, 2025. Mizuho Initiated an Outperform rating on August 05, 2025, and assigned a price target of $38. Oppenheimer initiated its ‘Outperform’ rating for MBX, as published in its report on July 16, 2025. Citizens JMP’s report from April 10, 2025 suggests a price prediction of $38 for MBX shares, giving the stock a ‘Mkt Outperform’ rating. Stifel also rated the stock as ‘Buy’.
Analysis of MBX Biosciences Inc (MBX)
In order to gain a clear picture of MBX Biosciences Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -24.43% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 32.95, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.29M can be a very valuable indicator of volatility for MBX stock. On a monthly basis, the volatility of the stock is set at 9.69%, whereas on a weekly basis, it is put at 8.06%, with a gain of 11.34% over the past seven days. Furthermore, long-term investors anticipate a median target price of $64.43, showing growth from the present price of $27.39, which can serve as yet another indication of whether MBX is worth investing in or should be passed over.
How Do You Analyze MBX Biosciences Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 40.71%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 68.56% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
